FSMDX
Price
$37.20
Change
+$0.06 (+0.16%)
Updated
Nov 12 closing price
Net Assets
45.03B
LLSCX
Price
$29.36
Change
-$0.15 (-0.51%)
Updated
Nov 12 closing price
Net Assets
740.06M
Interact to see
Advertisement

FSMDX vs LLSCX

Header iconFSMDX vs LLSCX Comparison
Open Charts FSMDX vs LLSCXBanner chart's image
Fidelity Mid Cap Index
Price$37.20
Change+$0.06 (+0.16%)
VolumeN/A
Net Assets45.03B
Longleaf Partners Small-Cap
Price$29.36
Change-$0.15 (-0.51%)
VolumeN/A
Net Assets740.06M
FSMDX vs LLSCX Comparison Chart in %
View a ticker or compare two or three
VS
FSMDX vs. LLSCX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Hold and LLSCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 45B vs. LLSCX (740M). FSMDX pays higher dividends than LLSCX: FSMDX (1.26) vs LLSCX (0.11). FSMDX was incepted earlier than LLSCX: FSMDX (14 years) vs LLSCX (37 years). LLSCX (1.04) is less costly to investors than FSMDX (0.03). LLSCX is a more actively managed with annual turnover of: 27.00 vs. FSMDX (15.00). FSMDX has a lower initial minimum investment than LLSCX: FSMDX (0) vs LLSCX (10000). FSMDX annual gain was more profitable for investors over the last year : 4.21 vs. LLSCX (3.93). FSMDX return over 5 years is better than : 55.45 vs. LLSCX (33.85).
FSMDXLLSCXFSMDX / LLSCX
Total Expense Ratio0.030.953%
Annual Report Gross Expense Ratio0.031.042%
Fund Existence14 years37 years-
Gain YTD10.2467.310140%
Front LoadN/AN/A-
Min. Initial Investment010000-
Min. Initial Investment IRAN/AN/A-
Net Assets45B740M6,081%
Annual Yield % from dividends1.260.111,190%
Returns for 1 year4.213.93107%
Returns for 3 years41.4637.36111%
Returns for 5 years55.4533.85164%
Returns for 10 years143.8225.57562%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAMI44.540.56
+1.27%
Acadian Asset Management Inc
TAVIU10.44N/A
N/A
Tavia Acquisition Corp
SCM12.07-0.01
-0.08%
STELLUS CAPITAL INVESTMENT Corp
CYTK65.94-0.56
-0.84%
Cytokinetics
CUE0.67-0.02
-2.25%
Cue Biopharma